HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akina Tanaka Selected Research

Macular Edema

6/2022Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akina Tanaka Research Topics

Disease

1Paratuberculosis (Johne's Disease)
10/2022
1Retinal Vein Occlusion
06/2022
1Edema (Dropsy)
06/2022
1Macular Edema
06/2022
1Inflammation (Inflammations)
02/2019
1Disease Progression
02/2019

Drug/Important Bio-Agent (IBA)

2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 02/2019
1Monoclonal AntibodiesIBA
10/2022
1AntigensIBA
10/2022
1CTLA-4 AntigenIBA
10/2022
1ProstaglandinsIBA
10/2022
1Ranibizumab (Lucentis)FDA Link
06/2022
1CytokinesIBA
02/2019

Therapy/Procedure

1Aftercare (After-Treatment)
06/2022
1Therapeutics
02/2019